HomeNDC LookupRxCUI directory › RxCUI 1666781

1 ML atropine sulfate 0.4 MG/ML Injection — RxCUI 1666781

RxNorm drug concept · Semantic clinical drug
RxCUI 1666781 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 11 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1666781
Official name1 ML atropine sulfate 0.4 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asatropine sulfate 0.4 MG per 1 ML Injection; atropine sulfate 0.4 MG in 1 ML Injection
FDA products mapped11
Package NDCs mapped11
Reported Medicaid activity (SDUD)8,777 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Atropine Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's completely expected with atropine — it's actually doing its job. The drop temporarily shuts down the muscle that controls your pupil and your eye's ability to focus, and tho...
  • Why does my vision stay blurry and my eyes stay sensitive to light for so long after using these drops?
  • Good question! When one eye is significantly stronger than the other, the brain tends to ignore the weaker eye. Putting an atropine drop in the stronger eye blurs it on purpose, so...
  • My child's doctor prescribed these drops for lazy eye — how does that work?
📖 Read our full Atropine Ophthalmic guide →

🕸️ Concept Web — How 1 ML atropine sulfate 0.4 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML atropine sulfate 0.4 MG/ML Injection RxCUI 1666781

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Atropine 1223
    • Atropine sulfate 153971
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Atropine Injection 1666780
    • Atropine sulfate Injection 2647254
    • Atropine Injectable Product 1154988
    • Atropine sulfate Injectable Product 2659493
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Atropine sulfate 0.4 MG/ML 1190555

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Atropine sulfate 0.4 MG/ML SCDC · 1190555
  • Atropine Injection SCDF · 1666780
  • Atropine sulfate Injection SCDFP · 2647254
  • Atropine Injectable Product SCDG · 1154988
  • Atropine sulfate Injectable Product SCDGP · 2659493

📦 FDA Products & Package NDCs

11 products · 11 package NDCs
11 package NDCs map to RxCUI 1666781 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00404-9802-01 1 VIAL, GLASS in 1 BAG (0404-9802-01) / 1 mL in 1 VIAL, GLA... Atropine Sulfate Henry Schein, Inc 2024-08-22
00517-1001-25 25 VIAL, GLASS in 1 TRAY (0517-1001-25) / 1 mL in 1 VIAL, G... Atropine Sulfate American Regent, Inc. 2022-08-02
00517-1004-25 25 VIAL, GLASS in 1 TRAY (0517-1004-25) / 1 mL in 1 VIAL, G... Atropine Sulfate American Regent, Inc. 2022-08-02
00641-6274-25 25 VIAL in 1 CARTON (0641-6274-25) / 1 mL in 1 VIAL (0641-6... Atropine Sulfate Hikma Pharmaceuticals USA Inc. 2025-11-07
00641-6275-25 25 VIAL in 1 CARTON (0641-6275-25) / 1 mL in 1 VIAL (0641-6... Atropine Sulfate Hikma Pharmaceuticals USA Inc. 2025-11-07
51662-1627-03 25 POUCH in 1 CASE (51662-1627-3) / 1 VIAL, GLASS in 1 POUC... Atropine sulfate HF Acquisition Co LLC, DBA HealthFirst 2023-10-02
70069-0631-25 25 VIAL in 1 CARTON (70069-631-25) / 1 mL in 1 VIAL (70069-... Atropine Sulfate Somerset Therapeutics, LLC 2024-07-04
70069-0641-25 25 VIAL in 1 CARTON (70069-641-25) / 1 mL in 1 VIAL (70069-... Atropine Sulfate Somerset Therapeutics, LLC 2024-07-04
71872-7312-01 1 VIAL, GLASS in 1 BAG (71872-7312-1) / 1 mL in 1 VIAL, GLA... Atropine Sulfate Medical Purchasing Solutions, LLC 2023-10-06
71872-7341-01 1 VIAL in 1 BAG (71872-7341-1) / 1 mL in 1 VIAL Atropine Sulfate Medical Purchasing Solutions, LLC 2025-01-06
84549-0631-25 1 mL in 1 VIAL (84549-631-25) Atropine Sulfate ProPharma Distribution 2025-09-16
Observed labelers: American Regent, Inc. (2) · Hikma Pharmaceuticals USA Inc. (2) · Medical Purchasing Solutions, LLC (2) · Somerset Therapeutics, LLC (2) · Henry Schein, Inc (1) · HF Acquisition Co LLC, DBA HealthFirst (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0462 Atropine sulf, nte, 0.01 mg 8 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.